Market Place
Sourcing Support
Bluejay Diagnostics Announces Reverse Stock Split
13 Nov 2024 //
GLOBENEWSWIRE
Bluejay Diagnostics Closes $8.75M Underwritten Public Offering
28 Jun 2024 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces Pricing of $8.75 Million Public Offering
27 Jun 2024 //
GLOBENEWSWIRE
SYMON-I of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients
26 Jun 2024 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces Reverse Stock Split
17 Jun 2024 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
02 Jan 2024 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering
28 Dec 2023 //
GLOBENEWSWIRE
Bluejay Announces Initiation of Study Evaluating Symphony IL-6
27 Dec 2023 //
GLOBENEWSWIRE
Bluejay Announces $1.59M Registered Direct Offering Priced under Nasdaq Rules
25 Aug 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Reports Second Quarter 2023 Financial Results
16 Aug 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement
10 Aug 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces Reverse Stock Split
21 Jul 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy
19 May 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Reports First Quarter 2023 Financial Results
10 May 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Reports 2022 Financial Results
20 Mar 2023 //
GLOBENEWSWIRE
Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
16 Feb 2023 //
GLOBENEWSWIRE
Bluejay to Host Opinion Leader Event on IL-6 Testing in Critical Care Settings
16 Aug 2022 //
GLOBENEWSWIRE
Bluejay raises $41 million in Series B round to drive clinical trials
16 Aug 2022 //
GLOBENEWSWIRE
Positive Clinical Results for Bluejay’s Symphony IL-6 Test at AACC 2022
27 Jul 2022 //
GLOBENEWSWIRE
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
06 Jul 2022 //
GLOBENEWSWIRE
FDA Agrees to Consider Bluejay`s Plan to Pursue De Novo Regulatory Pathway
09 Jun 2022 //
GLOBENEWSWIRE
Bluejay Diagnostics Appoints Edwin Rule as VP, Regulatory, Quality, Compliance
28 Mar 2022 //
GLOBENEWSWIRE
Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer
24 Mar 2022 //
GLOBENEWSWIRE
Bluejay Diagnostics, Inc. Reports Q4 and FY 2021 Financial Results
10 Mar 2022 //
GLOBENEWSWIRE
Bluejay Diagnostics Announces its Pre-Submission Filing Package
31 Jan 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.